Comment and reply on: Insulin therapy in type 2 diabetes: insulin analogue mix 50, a potential role in reducing postprandial hyperglycaemia and cardiovascular disease

Author： Gude AB J   Christiansen J S  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.11, Iss.9, 2010-06, pp. : 1603-1604

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Defining the Role of Insulin Lispro in the Management of Postprandial Hyperglycaemia in Patients with Type 2 Diabetes Mellitus

By Giugliano D.  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 199-210

Adis International

Access to resources Recommend Favorite

Preferred insulin analogue regimens in poorly controlled type 2 diabetes

By  

Inpharma, Vol. 1, Iss. 1545, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Insulin analogue therapy in pregnancies complicated by diabetes mellitus

By González Claudio   Santoro Silvina   Salzberg Susana   Di Girolamo Guillermo   Alvariñas Jorge  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 5, 2005-05 ,pp. : 735-742

Informa Healthcare

Access to resources Recommend Favorite

Insulin detemir is an effective long-acting human insulin analogue for the treatment of type 1 and 2 diabetes mellitus

By Adis International Limited  

Drugs & Therapy Perspectives, Vol. 21, Iss. 9, 2005-09 ,pp. : 1-4

Adis International

Access to resources Recommend Favorite

The role of IGF-1 resistance in obesity and type 2 diabetes-mellitus-related insulin resistance and vascular disease

By Gatenby Victoria K   Kearney Mark T  

Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 12, 2010-12 ,pp. : 1333-1342

Informa Healthcare

Access to resources Recommend Favorite